http://www.socialpicks.com/ideas/show/26...

read Havrillas review on EXAS and I will be glad to discuss this DIAGNOSTIC play on our AMAG board.

I have a small position of 1100 shares in EXAS but I am building a much larger position in another diagnostic play(email me for name at yahoo).I will not discuss other play openly on this board,too many vermin!

I like these two companies for the LONG TERM...they are buy and hold big science plays whose futures are tied to EARLY accurate diagnosis of CRC,others! I think we see rapid growth and therefore consolidation in the group and I want to own a couple names who I think survive/thrive!

Huge market potential to those diagnostic plays that can execute in the current designer cancer tmx market!Payors will only allow tmx of cancers w/ specific genetic mutations IDENTIFIED the luxury of drugs such as Herceptin,Tykerb,Sutent,Erbitux others moving forward!

new paradigm shift coming if not already here,IMO!

frank